BIOMAT Database Logo BIOMAT Database Logo

[L-Dopa therapy of the Parkinson syndrome]. 1971

K Poeck

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Poeck
[L-dopa therapy of parkinson syndrome].
February 1985, Der Nervenarzt,
K Poeck
[Parkinson therapy with L-dopa].
January 1971, Deutsche medizinische Wochenschrift (1946),
K Poeck
[The problems of L-dopa therapy in the course of Parkinson syndrome].
May 1989, Fortschritte der Neurologie-Psychiatrie,
K Poeck
[Parkinson syndrome, frontal tumor and L-dopa].
January 1984, Revue neurologique,
K Poeck
[Current treatment of Parkinson syndrome with L-dopa].
May 1972, Polski tygodnik lekarski (Warsaw, Poland : 1960),
K Poeck
[Tumoral Parkinson hemi-syndrome sensitive to L-dopa].
June 1994, Presse medicale (Paris, France : 1983),
K Poeck
[L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
August 1972, Deutsche medizinische Wochenschrift (1946),
K Poeck
[Parkinson, what's new? L-Dopa, The Lancet answers].
June 2014, Revue medicale suisse,
K Poeck
For Parkinson patients L-Dopa spells hope.
January 1970, Alumnae magazine (Columbia University-Presbyterian Hospital School of Nursing Alumnae Association),
K Poeck
An evaluation of L-dopa in Parkinson patients.
January 1969, Transactions of the American Neurological Association,
Copied contents to your clipboard!